Antibiotic Stewardship
Cluster RCT | Effect of an antibiotic stewardship intervention to improve antibiotic prescribing for suspected UTI in older adults
24 Feb, 2023 | 13:58h | UTCSummary: The study evaluated the effectiveness of a multifaceted antibiotic stewardship intervention to improve antibiotic prescribing for suspected urinary tract infections (UTI) in frail older adults. The study was a pragmatic, parallel, cluster-randomized controlled trial conducted in four European countries and included 1041 frail older adults aged 70 or older. The intervention involved a decision tool for appropriate antibiotic use, supported by a toolbox with educational materials. The control group provided care as usual. The primary outcome was the number of antibiotic prescriptions for suspected UTI per person year, and secondary outcomes included incidence of complications, hospital referrals, admissions, and mortality. The results showed that the intervention group had a lower rate of receiving an antibiotic prescription for a suspected UTI (0.27 per person year) compared to the control group (0.58 per person year), with no increase in complications or adverse events.
Commentary: Trial: Stewardship intervention cuts antibiotic prescribing for suspected urinary infections – CIDRAP
Related:
Case-Control Study | Current pyuria cut-offs may promote inappropriate UTI diagnosis in older women
USPSTF Recommendation Statement: Screening for Asymptomatic Bacteriuria in Adults
Guideline | Diagnosis and treatment of Helicobacter pylori
24 Feb, 2023 | 13:53h | UTCRelated:
SR | The impact of Antimicrobial Stewardship Programs in pediatric emergency departments and primary care
24 Feb, 2023 | 13:20h | UTC
Review | When and how to use MIC in clinical practice?
24 Feb, 2023 | 13:28h | UTCWhen and How to Use MIC in Clinical Practice? – Antibiotics
Commentary on Twitter
https://twitter.com/ABsteward/status/1616852667124400129
Antibiotic allergy de-labeling: a pathway against antibiotic resistance
23 Feb, 2023 | 13:12h | UTCAntibiotic Allergy De-Labeling: A Pathway against Antibiotic Resistance – Antibiotics
Related:
M-A: Most patients with allergy to Penicillin can be given Cefazolin
Podcast: A Clinical Pharmacologist’s Perspective on Penicillin Allergy
Study: Development and Validation of a Penicillin Allergy Clinical Decision Rule
NICE: Double Check Patients with ‘Penicillin Allergy’ to Avoid Increased MRSA Risk
Case-Control Study | Current pyuria cut-offs may promote inappropriate UTI diagnosis in older women
22 Feb, 2023 | 12:43h | UTCSummary: The presence of pyuria is commonly used as the cornerstone of urinary tract infection (UTI) diagnosis. However, over 90% of asymptomatic bacteriuria (ASB) patients also have pyuria, which can lead to unnecessary treatment. This is especially problematic in older women who may have pre-existing lower urinary tract symptoms, cognitive impairment, and a high prevalence of ASB. This study examined the diagnostic accuracy of different pyuria thresholds for UTI in older women. The study found that current pyuria cut-offs (10 leukocytes/µl) are too low and promote inappropriate UTI diagnosis in older women. A threshold of 300 leukocytes/µl is suggested as a considerable improvement, increasing specificity to avoid overtreatment, while still maintaining a fair sensitivity. This has implications for patient care, antimicrobial stewardship efforts, and research. The impact of higher cut-off values on prescription behavior and UTI related outcomes in older women deserves further study.
Related:
USPSTF Recommendation Statement: Screening for Asymptomatic Bacteriuria in Adults
Commentary on Twitter
Presence of pyuria remains the cornerstone of UTI diagnosis However, >90% of ASB patients have pyuria,prompt unnecessary Rx
🆕️⚡️⚡️study: current pyuria cut-off is too low promote inappropriate UTI diagnosis in older women suggesting a new higher cut offhttps://t.co/qAGdwSTiU6 pic.twitter.com/Vr63RnuMv1— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) February 20, 2023
Article under a https://creativecommons.org/licenses/by-nc-nd/4.0/ license
Bacteriuria in older adults triggers confusion in healthcare providers: a mindful pause to treat the worry
22 Feb, 2023 | 12:42h | UTCRelated:
USPSTF Recommendation Statement: Screening for Asymptomatic Bacteriuria in Adults
Commentary on Twitter
FANTASTIC⚡️⚡️
The evidence base for refraining from screening for or treating ASB in elderly is strong,but both practices remain prevalent
Bacteriuria in older adults triggers confusion in healthcare providers:A mindful pause to treat the worry #IDTwitter https://t.co/7ispdtFeFB pic.twitter.com/kOB5eGKkAc— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) January 10, 2023
Under a http://creativecommons.org/licenses/by/4.0/ license
Bacteremia | ED presentations, evaluation, and management
22 Feb, 2023 | 12:25h | UTCBacteremia: ED Presentations, Evaluation, and Management – emDocs
M-A | Global status of azithromycin and erythromycin resistance rates in Neisseria gonorrhoeae
17 Feb, 2023 | 12:58h | UTC
Case Reports | Seventeen cases of daptomycin-induced eosinophilic pneumonia in bone and joint infections
17 Feb, 2023 | 12:54h | UTC
M-A | Association between antimicrobial stewardship programs and antibiotic use globally
16 Feb, 2023 | 15:21h | UTCCommentaries:
Antimicrobial Stewardship Programs Beneficial for Cutting Antibiotic Use – HealthDay
M-A | Worldwide prevalence of antibiotic-associated Stevens-Johnson syndrome and toxic epidermal necrolysis
16 Feb, 2023 | 15:04h | UTCSummary: The article examined the prevalence Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) associated with antibiotics worldwide. The analysis included 38 studies involving 2,917 patients, which showed that 28% of SJS/TEN cases were associated with antibiotics. Among antibiotic-associated SJS/TEN, the sulfonamide class was associated with 32% of cases, followed by penicillins, cephalosporins, fluoroquinolones, and macrolides.
Article: Worldwide Prevalence of Antibiotic-Associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysis – JAMA Dermatology (free for a limited period)
*Note: This summary was created through the collaboration of a medical editor and ChatGPT.
RCT | Antimicrobial therapy for 7 days is inferior to treatment for 14 days in men with febrile urinary tract infection
15 Feb, 2023 | 16:11h | UTCSummary: This study aimed to compare the effectiveness of 7-day versus 14-day antibiotic treatment for febrile urinary tract infections in men. The multicenter randomized, double-blind, placebo-controlled non-inferiority trial enrolled 282 men from 27 centers in France. The primary endpoint was treatment success, defined as a negative urine culture, the absence of fever, and no subsequent antibiotic treatment between the end of treatment and 6 weeks after day 1. The results showed that the 14-day treatment was superior to the 7-day treatment, with a treatment success rate of 77.6% versus 55.7%, respectively. Adverse events were similar in both groups, and rectal carriage of resistant Enterobacterales did not differ. Therefore, the study concludes that treatment with ofloxacin for 7 days is inferior to 14 days for febrile UTI in men and should not be recommended.*
Article: Antimicrobial for 7 or 14 days for febrile urinary tract infection in men: a multicenter noninferiority double blind placebo-controlled, randomized clinical trial – Clinical Infectious Diseases (link to abstract – $ for full-text)
*Note: This summary was created through the collaboration of a medical editor and ChatGPT.
Retrospective Study | Post-cardiac surgery fungal mediastinitis: clinical features, pathogens and outcome
15 Feb, 2023 | 15:40h | UTCPost-cardiac surgery fungal mediastinitis: clinical features, pathogens and outcome – Critical Care
Single-arm study | Effects of SER-109 as an investigational microbiome therapeutic in recurrent C. difficile infection
14 Feb, 2023 | 10:47h | UTCSummary: This was a phase 3, open-label, single-arm trial of 263 adults with recurrent Clostridioides difficile Infection (CDI). The trial aimed to evaluate the safety and rate of CDI recurrence after administration of the investigational microbiome therapeutic SER-109. The trial found that SER-109 was well tolerated and the overall rate of recurrent CDI was low, regardless of the number of prior recurrences, demographics, or diagnostic approach.
(By ChatGPT, reviewed and edited)
Commentary: Phase 3 trial provides more positive data for recurrent C diff microbiome drug – CIDRAP
Related:
Cohort study | Epidemiology and outcomes of hospital-acquired bloodstream infections in ICU patients
14 Feb, 2023 | 10:44h | UTCEpidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study – Intensive Care Medicine (if the link is paywalled, try this one)
Commentary on Twitter
Hospital‑acquired bloodstream infections in #ICU, @EuroBact2
🧫mainly due to Gram -, widespread carbapenem resistant, DTR pathogens
🧫resistance associated w longer delays to adequate ABT therapy
At day-28
🧫mortality 37%
🧫16.1% discharged alive from 🏥
🖇️https://t.co/0T4FK2mxc5 pic.twitter.com/e0u50hMKqO— Intensive Care Medicine (@yourICM) February 11, 2023
Cohort Study | Global epidemiology of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases
14 Feb, 2023 | 10:43h | UTC
RCT | Azithromycin reduces the risk of maternal sepsis or death in women planning a vaginal birth
13 Feb, 2023 | 13:02h | UTCAzithromycin to Prevent Sepsis or Death in Women Planning a Vaginal Birth – New England Journal of Medicine (link to abstract – $ for full-text)
News Release: Single-dose antibiotic prevents maternal sepsis and death – NIH News
Commentaries:
In large study, a single antibiotic dose slashed rate of sepsis in childbirth – STAT
Dose of azithromycin found to cut risk of maternal death, sepsis in childbirth – CIDRAP
Guideline for management of septic arthritis in native joints
10 Feb, 2023 | 14:00h | UTC
SR | Mechanical plus oral antibiotic bowel preparation may prevent complications in elective colorectal surgery
10 Feb, 2023 | 13:53h | UTCRelated:
How to use biomarkers of infection or sepsis at the bedside: guide to clinicians
9 Feb, 2023 | 13:26h | UTC
Commentary on Twitter
Infection or #sepsis at bedside:
🧫 how to use biomarkers? Serial determinations & never as stand-alone test: do not miss clinical evaluation
🧫 pathogen‑specific & host‑response biomarkers? useful to provide additional data to optimize care
🧫 future
🖇️ https://t.co/Z3Hgb2I6o1 pic.twitter.com/bX4PanG2Et— Intensive Care Medicine (@yourICM) January 2, 2023
An analysis of national action plans for antimicrobial resistance—gaps and opportunities in strategies optimizing antibiotic use
7 Feb, 2023 | 13:48h | UTC
Commentary on Twitter
Online First: An analysis of existing national action plans for antimicrobial resistance—gaps and opportunities in strategies optimising antibiotic use in human populations https://t.co/Ox0sEwFWgQ pic.twitter.com/cjOVpIblnJ
— The Lancet Global Health (@LancetGH) February 6, 2023
Can the future of ID escape the inertial dogma of its past? The exemplars of shorter is better and oral is the new IV
7 Feb, 2023 | 13:34h | UTC
Guideline | Diagnosis and management of otitis media with effusion in children
6 Feb, 2023 | 13:23h | UTC
Rates of antimicrobial resistance in Helicobacter pylori isolates across the US and Europe
6 Feb, 2023 | 13:12h | UTCCommentary: Time to ditch clarithromycin for H. pylori? – MDedge
Commentary on Twitter
New #RedJournal study by Mégraud, et al., shows high antibiotic resistance rates in #Hpylori isolates across the US & EU and the need for antibiotic resistance surveillance and novel treatment strategies for H. pylori.
📕 Read more: https://t.co/JT6P0MnEdW@umfoodoc @cwhowden pic.twitter.com/5FeV3Wj6Dw
— AJG – The American Journal of Gastroenterology (@AmJGastro) November 14, 2022


